Xbira 250mg Tablet – Abiraterone Acetate 250 mg for Prostate Cancer
Xbira 250mg Tablet is an oral cancer medicine from Cipla. Each uncoated tablet contains Abiraterone Acetate I.P. 250 mg. It is prescribed for men whose prostate cancer is advanced and has spread beyond the prostate. Many prostate tumours rely on male hormones such as testosterone to keep growing. Abiraterone blocks an enzyme the body uses to make these hormones, including the small amounts produced in the adrenal glands and inside the tumour itself. With less hormone available, cancer cells receive weaker growth signals and the disease can be held back for longer. Treatment is normally taken together with a low-dose steroid such as prednisolone, which helps the body cope with the hormonal changes. Xbira is a specialist medicine that should be started and supervised by an oncologist, who will order regular blood tests and check blood pressure, potassium levels and liver function throughout the course of therapy.
Before starting Xbira, tell your oncologist about any heart, liver or adrenal problems, high blood pressure or low potassium, and list every other medicine you take. Regular follow-up visits are part of the treatment, because blood tests show how the body is responding and whether the dose needs adjusting. Taking the tablets at the same time each day helps keep a steady level of the medicine in the body. If a dose is missed, ask your doctor what to do rather than doubling the next one. Many patients stay on abiraterone for months or years, so consistent use and careful monitoring matter more than any single dose.
Key Benefits
- Best value: the 360-tablet pack has the lowest price per tablet.
- Helps slow the progress of advanced prostate cancer.
- Cuts the hormones that feed tumour growth.
- Convenient once-daily oral treatment.
- Works alongside steroid therapy.
- Made by Cipla, a well-known Indian pharma company.
Key Features
- Abiraterone Acetate 250 mg in every tablet.
- Uncoated tablet form.
- Sealed bottle of 120 tablets.
- Available in packs of 120, 240 and 360 tablets.
- Best value pack: 360 tablets at the lowest unit price.
- Manufactured in India by Cipla.
Key Ingredients
- Abiraterone Acetate I.P. – hormone-lowering anti-cancer agent.
- Standard tablet excipients.
How to Use
- Take exactly the dose your oncologist prescribes.
- Swallow each tablet whole with water.
- Do not crush, chew or break the tablets.
- Take on an empty stomach if your doctor advises it.
- Never change or stop the dose on your own.
Side Effects
- Tiredness or weakness.
- Swelling in the legs or ankles.
- Hot flushes and joint or muscle pain.
- High blood pressure or low potassium.
- Urinary tract infection, diarrhoea or nausea.
Call your doctor at once for yellow skin or eyes, dark urine, chest pain, irregular heartbeat or severe muscle weakness.
Precautions
- Use only under an oncologist’s supervision.
- Tell your doctor about liver, heart or adrenal problems.
- Blood pressure, potassium and liver tests are needed regularly.
- Wash hands after touching tablets; pregnant women should not handle them.
- Store below 30°C, away from light, moisture and children.
Legal Disclaimer
Xbira 250mg Tablet is a prescription-only medicine to be used under the supervision of a qualified oncologist, who will decide whether it suits you. This information is for education only and does not replace professional medical advice, diagnosis or treatment.


















Reviews
There are no reviews yet.